IOVANCE BIOTHERAPEUTICS, INC. — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/0589bc62-da31-4a71-b44e-5043d042f1b3/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $263.5M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-018899 |
| FY 2024 | $164.1M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-001834 |
| FY 2023 | $1.2M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002036 |
| FY 2018 | $0 | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-010702 |
| FY 2017 | $0 | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-014151 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-013535 |
| FY 2015 | $0 | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-087506 |
| FY 2014 | $0 | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-016315 |
| FY 2013 | $0 | 2007-12-17 – 2013-12-31 | evidence 0001513160-14-000023 |
| FY 2012 | $0 | 2007-09-17 – 2013-03-31 | evidence 0001513160-13-000061 |
| FY 2011 | $0 | 2007-09-17 – 2012-03-31 | evidence 0001513160-12-000038 |
| FY 2010 | $0 | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-018611 |
| FY 2009 | $0 | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-018611 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
IOVANCE BIOTHERAPEUTICS, INC. — all facts · Net Income · Operating Income